Table 1.
Demographics and clinical characteristics for individuals randomized to iCAN-DO or standard care.
| Characteristic | Randomized (n = 245) |
Completed 24-month assessment (n = 117) |
||
|---|---|---|---|---|
| iCAN-DO (n = 124) | Standard care (n = 121) | iCAN-DO (n = 55) | Standard care (n = 63) | |
| Age, years | ||||
| Mean (SD) | 57.3 (10.6) | 57.0 (10.7) | 60.4 (9.3) | 58 (10.9) |
| Min-max | 29–86 | 33–75 | ||
| Sex n (%)a | ||||
| Female | 93 (75) | 81 (67) | 39 (71) | 37 (59) |
| Male | 31 (25) | 40 (33) | 16 (29) | 26 (41) |
| Marital status n (%)a | ||||
| Single/divorced/widowed | 20 (16) | 13 (11) | 3 (5) | 5 (8) |
| Married/cohabiting | 95 (77) | 98 (81) | 48 (87) | 52 (83) |
| Living apart together | 6 (5) | 6 (5) | 3 (5) | 3 (5) |
| Other | 3 (2) | 4 (2) | 1 (2) | 3 (5) |
| Education n (%)a | ||||
| Elementary school | 18 (15) | 23 (19) | 8 (15) | 12 (19) |
| High school | 36 (29) | 42 (35) | 14 (25) | 23 (37) |
| University/university college ≤ 3 years | 29 (23) | 28 (23) | 10 (18) | 14 (22) |
| University/university college > 3 years | 41 (33) | 28 (23) | 23 (42) | 14 (22) |
| Country of birth n (%)a | ||||
| Sweden | 110 (89) | 112 (93) | 47 (85) | 58 (92) |
| Outside Sweden | 14 (11) | 8 (7) | 8 (15) | 5 (8) |
| Tumor origin, distant metastasis, and planned treatment n (%)b | ||||
| Breast cancer | 84 (68) | 71 (59) | 37 (67) | 35 (56) |
| Distant metastasis | 2 (2) | 1 (1) | ||
| Breast conserving surgery | 55 (65) | 47 (66) | ||
| Mastectomy | 27 (32) | 23 (32) | ||
| Chemotherapy | 34 (41) | 36 (51) | ||
| Radiotherapy | 78 (93) | 63 (89) | ||
| Endocrine treatment | 60 (71) | 54 (76) | ||
| Antibody treatment | 8 (10) | 8 (10) | ||
| Prostate cancer | 24 (20) | 28 (23) | 14 (25) | 20 (32) |
| Distant metastasis | 1 (4) | 3 (11) | ||
| Prostatectomy | 7 (32) | 10 (36) | ||
| Radiotherapy | 12 (55) | 10 (36) | ||
| Endocrine treatment | 8 (36) | 8 (29) | ||
| Colorectal cancer | 14 (12) | 22 (18) | 4 (7) | 8 (13) |
| Distant metastasis | 2 (14) | 2 (9) | ||
| Segmental colon resection | 13 (93) | 19 (95) | ||
| Stoma | 4 (29) | 9 (45) | ||
| Chemotherapy | 6 (43) | 16 (80) | ||
| Radiotherapy | 5 (36) | 12 (60) | ||
| Monthly income n (%) | ||||
| Low < 1244 € | 5 (4) | 5 (4) | 4 (7) | 0 (0) |
| Average 1244–4976 € | 82 (66) | 79 (65) | 30 (55) | 38 (60) |
| High > 4976 € | 5 (4) | 3 (3) | 3 (5) | 1 (2) |
| Unknown (not responded) | 32 (26) | 34 (28) | 18 (33) | 24 (38) |
| Psychosocial support n (%)c | ||||
| Yes | 7 (6) | 7(6) | 9 (16) | 11 (17) |
| No | 117(94) | 114 (94) | 46 (84) | 52 (83) |
| Currently using psychotropic drugs n (%) | ||||
| Yes | 24 (19) | 24 (20) | 14 (25) | 14 (22) |
| No | 100 (81) | 97 (80) | 41 (75) | 49 (78) |
| Computer experience n (%) | ||||
| Very inexperienced | 5 (4) | 6 (5) | 1 (2) | 2 (3) |
| Quite inexperienced | 12 (10) | 12 (10) | 6 (11) | 8 (13) |
| Quite experienced | 54 (44) | 45 (38) | 24 (44) | 23 (36) |
| Very experienced | 52 (42) | 57 (48) | 24 (44) | 30 (48) |
a
Where numbers in a category do not add up to n or 100%, there is missing data.
b
Individuals may have been planned for more than one treatment modality.
c
Psychosocial support was defined as seeing a therapist at least once a month.